ID: 17 | Pages: 144 | December 2016 | Region: North America
The North America biomaterials market is poised to reach $43.99 Billion by 2020 from an estimated $22.75 Billion in 2015, growing at a CAGR of 13.6%. In a short span of time, many patients throughout the world have the quality of their lives improved with the aid of some kind of implanted device. The materials from which these devices are built include metals, ceramics, polymers, and an array of composites. As we reach the end of the 20th century, the success of using these materials is increasing, both because of improved surgical skill, and improved understanding of how the body interacts with such devices.
Due to the increase in aging population in the North American countries, there is a strong demand for usage of biomaterials in cardiology, neurology, wound healing and plastic surgery. Further, research on advancements in medical technology for the efficient functionality of medical implants, increased grants and funding from government bodies, are some of the factors driving the growth of North America biomaterials market. Besides, new technologies such as hydrogen scaffolding and decellularized dermal matrixes for grafting will contribute to the market in growing at a healthy rate throughout the forecast period.
However, adverse reaction to biomaterial implants, inflammation and fracture issues, stringent FDA regulations, high cost associated with manufacturing are the major factors limiting the progress of North America biomaterials market.
Based on the types of material, the North America biomaterials market is categorized into ceramic, metallic, polymers, and natural biomaterials. Polymers will have the fastest growth rate in the coming years owing to its increased applications in healthcare and distinct material properties such as bio- inertness, flexibility, longevity, biocompatibility and durability. With the rising incidence of ophthalmic disorders, the mainstream usage of polymers for ophthalmological purposes will surge in the next few years.
Further, based on application, the market is segmented into orthopaedic, dental, cardiovascular, plastic surgery, wound healing, ophthalmology, tissue engineering, neurological /central nervous systems, and other applications which include drug delivery systems, bariatric surgery, gastrointestinal and urinary applications.
Moreover, on the basis of geography, the North America market is analysed under various regions namely, USA and Canada. North America is poised to account for the largest share of the biomaterials market.
Some of the key players in the North America biomaterials market include Royal DSM, Zimmer Biomet Holdings, Inc., Evonik Industries AG, Wright Medical Technology, Inc., Corbion N.V., Berkeley Advanced Biomaterials, Bayer AG, Carpenter Technology Corporation, Covalon Technologies Ltd., BASF SE, Invibio Ltd., Inc., CAM Bioceramics BV, and Collagen Matrix, Inc.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Analysis Design
2.3 Research Phases
2.3.1 Secondary Research
2.3.2 Primary Research
2.3.3 Econometric Modelling
2.3.4 Expert Validation
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Material type
5.2 By Application
5.2.4 Plastic surgery
5.2.5 Wound healing
5.2.7 Tissue engineering
6. Geographical Analysis
6.2 United States
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Collagen Matrix, Inc
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Zimmer Biomet Holdings, Inc
8.3 Evonik Industries AG
8.4 Wright Medical Technology, Inc.,
8.5 Corbion N.V
8.6 Berkeley Advanced Biomaterials
8.7 Bayer AG
8.8 Carpenter Technology Corporation
8.9 Covalon Technologies Ltd.
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.1 Market Outlook
10.2 Investment Opportunities
a) List of Tables
b) List of Figures
|Title||Price||Add To Cart|
|Protein Expression Market by Expression Systems (Yeast Expression, Insect Expression, Cell-Free Expr|
|Latin America Artificial Organs and Bionics Market by Product (Artificial Organs, Bionics) by Techno|
Or follow us on social platform
© 2017 Market Data Forecast
All Rights Reserved.